Copyright Reports & Markets. All rights reserved.

Global Fludeoxyglucose (18F) Radionuclide Injection Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Fludeoxyglucose (18F) Radionuclide Injection

      • 1.1 Definition of Fludeoxyglucose (18F) Radionuclide Injection
      • 1.2 Fludeoxyglucose (18F) Radionuclide Injection Segment by Type
        • 1.2.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Cancer
        • 1.2.3 Coronary Artery Disease
        • 1.2.4 Others
      • 1.3 Fludeoxyglucose (18F) Radionuclide Injection Segment by Applications
        • 1.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Diagnostics Center
      • 1.4 Global Fludeoxyglucose (18F) Radionuclide Injection Overall Market
        • 1.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue (2014-2025)
        • 1.4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Production (2014-2025)
        • 1.4.3 North America Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
        • 1.4.4 Europe Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
        • 1.4.5 China Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
        • 1.4.6 Japan Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)
        • 1.4.8 India Fludeoxyglucose (18F) Radionuclide Injection Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Fludeoxyglucose (18F) Radionuclide Injection
      • 2.3 Manufacturing Process Analysis of Fludeoxyglucose (18F) Radionuclide Injection
      • 2.4 Industry Chain Structure of Fludeoxyglucose (18F) Radionuclide Injection

      3 Development and Manufacturing Plants Analysis of Fludeoxyglucose (18F) Radionuclide Injection

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Fludeoxyglucose (18F) Radionuclide Injection
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Fludeoxyglucose (18F) Radionuclide Injection Production and Capacity Analysis
      • 4.2 Fludeoxyglucose (18F) Radionuclide Injection Revenue Analysis
      • 4.3 Fludeoxyglucose (18F) Radionuclide Injection Price Analysis
      • 4.4 Market Concentration Degree

      5 Fludeoxyglucose (18F) Radionuclide Injection Regional Market Analysis

      • 5.1 Fludeoxyglucose (18F) Radionuclide Injection Production by Regions
        • 5.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production by Regions
        • 5.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Regions
      • 5.2 Fludeoxyglucose (18F) Radionuclide Injection Consumption by Regions
      • 5.3 North America Fludeoxyglucose (18F) Radionuclide Injection Market Analysis
        • 5.3.1 North America Fludeoxyglucose (18F) Radionuclide Injection Production
        • 5.3.2 North America Fludeoxyglucose (18F) Radionuclide Injection Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Fludeoxyglucose (18F) Radionuclide Injection Import and Export
      • 5.4 Europe Fludeoxyglucose (18F) Radionuclide Injection Market Analysis
        • 5.4.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Production
        • 5.4.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Fludeoxyglucose (18F) Radionuclide Injection Import and Export
      • 5.5 China Fludeoxyglucose (18F) Radionuclide Injection Market Analysis
        • 5.5.1 China Fludeoxyglucose (18F) Radionuclide Injection Production
        • 5.5.2 China Fludeoxyglucose (18F) Radionuclide Injection Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Fludeoxyglucose (18F) Radionuclide Injection Import and Export
      • 5.6 Japan Fludeoxyglucose (18F) Radionuclide Injection Market Analysis
        • 5.6.1 Japan Fludeoxyglucose (18F) Radionuclide Injection Production
        • 5.6.2 Japan Fludeoxyglucose (18F) Radionuclide Injection Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Fludeoxyglucose (18F) Radionuclide Injection Import and Export
      • 5.7 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Market Analysis
        • 5.7.1 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Production
        • 5.7.2 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Import and Export
      • 5.8 India Fludeoxyglucose (18F) Radionuclide Injection Market Analysis
        • 5.8.1 India Fludeoxyglucose (18F) Radionuclide Injection Production
        • 5.8.2 India Fludeoxyglucose (18F) Radionuclide Injection Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Fludeoxyglucose (18F) Radionuclide Injection Import and Export

      6 Fludeoxyglucose (18F) Radionuclide Injection Segment Market Analysis (by Type)

      • 6.1 Global Fludeoxyglucose (18F) Radionuclide Injection Production by Type
      • 6.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue by Type
      • 6.3 Fludeoxyglucose (18F) Radionuclide Injection Price by Type

      7 Fludeoxyglucose (18F) Radionuclide Injection Segment Market Analysis (by Application)

      • 7.1 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption by Application
      • 7.2 Global Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Share by Application (2014-2019)

      8 Fludeoxyglucose (18F) Radionuclide Injection Major Manufacturers Analysis

      • 8.1 Zevacor Pharma
        • 8.1.1 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.1.2 Zevacor Pharma Product Introduction, Application and Specification
        • 8.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Queen's PET Imaging
        • 8.2.1 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.2.2 Queen's PET Imaging Product Introduction, Application and Specification
        • 8.2.3 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Triad Isotopes
        • 8.3.1 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.3.2 Triad Isotopes Product Introduction, Application and Specification
        • 8.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 NCM USA Bronx
        • 8.4.1 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.4.2 NCM USA Bronx Product Introduction, Application and Specification
        • 8.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Spectron MRC
        • 8.5.1 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.5.2 Spectron MRC Product Introduction, Application and Specification
        • 8.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Petnet Solutions
        • 8.6.1 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.6.2 Petnet Solutions Product Introduction, Application and Specification
        • 8.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Shertech Laboratories
        • 8.7.1 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.7.2 Shertech Laboratories Product Introduction, Application and Specification
        • 8.7.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Precision Nuclear
        • 8.8.1 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Production Sites and Area Served
        • 8.8.2 Precision Nuclear Product Introduction, Application and Specification
        • 8.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Fludeoxyglucose (18F) Radionuclide Injection Market

      • 9.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Trend Analysis
        • 9.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Fludeoxyglucose (18F) Radionuclide Injection Regional Market Trend
        • 9.2.1 North America Fludeoxyglucose (18F) Radionuclide Injection Forecast 2019-2025
        • 9.2.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Forecast 2019-2025
        • 9.2.3 China Fludeoxyglucose (18F) Radionuclide Injection Forecast 2019-2025
        • 9.2.4 Japan Fludeoxyglucose (18F) Radionuclide Injection Forecast 2019-2025
        • 9.2.5 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Forecast 2019-2025
        • 9.2.6 India Fludeoxyglucose (18F) Radionuclide Injection Forecast 2019-2025
      • 9.3 Fludeoxyglucose (18F) Radionuclide Injection Market Trend (Product Type)
      • 9.4 Fludeoxyglucose (18F) Radionuclide Injection Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Fludeoxyglucose (18F) Radionuclide Injection Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
        Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
        United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.
        ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.

        The global Fludeoxyglucose (18F) Radionuclide Injection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Fludeoxyglucose (18F) Radionuclide Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fludeoxyglucose (18F) Radionuclide Injection market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Fludeoxyglucose (18F) Radionuclide Injection in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Fludeoxyglucose (18F) Radionuclide Injection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Zevacor Pharma
        Queen's PET Imaging
        Triad Isotopes
        NCM USA Bronx
        Spectron MRC
        Petnet Solutions
        Shertech Laboratories
        Precision Nuclear

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Cancer
        Coronary Artery Disease
        Others

        Segment by Application
        Hospitals
        Clinics
        Diagnostics Center

        Buy now